Novel approaches to P2Y12 inhibition and aspirin dosing

Novel approaches to P2Y12 inhibition and aspirin dosing

Aspirin and P2Y12 inhibitors remain commonly prescribed antiplatelet drugs in the treatment of atherothrombotic conditions. Despite established benefits of dual antiplatelet therapy (DAPT) in the setting of acute coronary syndromes, there remains residual ischemic risk in this group and the problem...

Full description

Bibliographic Details
Main Authors: William A. E. Parker, Robert F. Storey
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Platelets
Subjects:
aspirin
atherothrombosis
p2y12 inhibitors
Online Access:http://dx.doi.org/10.1080/09537104.2020.1714574

Similar Items

Similar Items